Ontology highlight
ABSTRACT:
SUBMITTER: Della Porta MG
PROVIDER: S-EPMC6086331 | biostudies-literature | 2017 Nov
REPOSITORIES: biostudies-literature
Della Porta M G MG Jackson C H CH Alessandrino E P EP Rossi M M Bacigalupo A A van Lint M T MT Bernardi M M Allione B B Bosi A A Guidi S S Santini V V Malcovati L L Ubezio M M Milanesi C C Todisco E E Voso M T MT Musto P P Onida F F Iori A P AP Cerretti R R Grillo G G Molteni A A Pioltelli P P Borin L L Angelucci E E Oldani E E Sica S S Pascutto C C Ferretti V V Santoro A A Bonifazi F F Cazzola M M Rambaldi A A
Leukemia 20170321 11
Allogeneic hematopoietic stem cell transplantation (allo-SCT) represents the only curative treatment for patients with myelodysplastic syndrome (MDS), but involves non-negligible morbidity and mortality. Crucial questions in clinical decision-making include the definition of optimal timing of the procedure and the benefit of cytoreduction before transplant in high-risk patients. We carried out a decision analysis on 1728 MDS who received supportive care, transplantation or hypomethylating agents ...[more]